Kenta Biotech AG
  • Home
  • Shop
  • Events
  • Courses
  • Services
  • Pricing
  • Company
    • News
    • Success Stories
    • About Us
  • Appointment
  • Contact us
  • 0
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
Kenta Biotech AG
  • 0
    • Home
    • Shop
    • Events
    • Courses
    • Services
    • Pricing
    • Company
      • News
      • Success Stories
      • About Us
    • Appointment
    • Contact us
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
  1. Products
  2. Elisa Assay Kit
Public Pricelist
Public Pricelist
Sort By: Featured
Featured Newest Arrivals Name (A-Z) Price - Low to High Price - High to Low

Elisa Assay Kit

[0812-E1465Hu] Human LIG3/ DNA ligase 3 ELISA Test
Human LIG3/ DNA ligase 3 ELISA Test
600.00 € 600.0 EUR
[0855-ELK1160-96T] Human LEP(Leptin) ELISA Test - 96 Tests
Human LEP(Leptin) ELISA Test - 96 Tests
432.00 € 432.0 EUR
[0399-CSB-E13606h-96T] Human L-Carnitine ELISA Test - 96 wells plate
Human L-Carnitine ELISA Test - 96 wells plate
1,040.00 € 1040.0 EUR
[0544-MBS728648-96T] Human L-Arginine ELISA Test - 96 wells plate
Human L-Arginine ELISA Test - 96 wells plate
1,030.00 € 1030.0 EUR
[0801-EIA06660h] Human L-Arginine (L-Arg) ELISA Test - 96 wells plate
Human L-Arginine (L-Arg) ELISA Test - 96 wells plate
500.00 € 500.0 EUR
[0576-201-12-2782 -96T] Human Klotho(KL)ELISA Test, 96 test
Human Klotho(KL)ELISA Test, 96 test
560.00 € 560.0 EUR
[0576-201-12-2783-96T] Human Klotho Beta(KLb)ELISA Test, 96 test
Human Klotho Beta(KLb)ELISA Test, 96 test
560.00 € 560.0 EUR
[0740-AE36649HU-48T] Human Klotho (KL) ELISA Test 48T
Human Klotho (KL) ELISA Test 48T
574.00 € 574.0 EUR
[0812-SL1031Hu] Human Kidney injury molecule 1,Kim-1 ELISA Test - 96wells
Human Kidney injury molecule 1,Kim-1 ELISA Test - 96wells
516.00 € 516.0 EUR
[0855-ELK9026-96T] Human KYN(Kynurenine) ELISA Test - 96T
Human KYN(Kynurenine) ELISA Test - 96T
500.00 € 500.0 EUR
[0763-E-EL-H6099-96T] Human KISS1(Kisspeptin 1) ELISA Test - 96T
Human KISS1(Kisspeptin 1) ELISA Test - 96T
500.00 € 500.0 EUR
[0855-ELK6625-96T] Human Irisin ELISA Test - 96T
Human Irisin ELISA Test - 96T
520.00 € 520.0 EUR
[0772-E0090Hu-96T] Human Interleukin 6, IL-6 ELISA Test-96T
Human Interleukin 6, IL-6 ELISA Test-96T
580.00 € 580.0 EUR
[0399-CSB-E04638h-96T] Human Interleukin 6 (IL-6) ELISA Test - 96 wells plate
Human Interleukin 6 (IL-6) ELISA Test - 96 wells plate
694.00 € 694.0 EUR
[00399-CSB-E13000h-96T] Human Interleukin 33(IL-33) ELISA Test - 96T
Human Interleukin 33(IL-33) ELISA Test - 96T
1,150.00 € 1150.0 EUR
[0866-RDR-IL31-Hu-96T] Human Interleukin 31 (IL31) ELISA Test-96T
Human Interleukin 31 (IL31) ELISA Test-96T
650.00 € 650.0 EUR
[0399-CSB-E08053h-96T] Human Interleukin 1β,IL-1β ELISA Test - 96T
Human Interleukin 1β,IL-1β ELISA Test - 96T
750.00 € 750.0 EUR
[0576-201-12-0144-96T] Human Interleukin 1β(IL-1β)ELISA Test, 96 tests
Human Interleukin 1β(IL-1β)ELISA Test, 96 tests
560.00 € 560.0 EUR
[0772-E0143Hu-96T] Human Interleukin 1Β, IL-1B ELISA Test-96T
Human Interleukin 1Β, IL-1B ELISA Test-96T
580.00 € 580.0 EUR
[0772-E0102Hu-96T] Human Interleukin 10, IL-10 ELISA Test-96T
Human Interleukin 10, IL-10 ELISA Test-96T
580.00 € 580.0 EUR
  • 63
  • 64
  • 65
  • 66
  • 67

Clear Filters



Respiratory syncytial virus (RSV) infections are the most common cause of hospitalization in early childhood, accounting for 57 000 to 120 000 hospitalizations each year in the United States. RSV is causing annual epidemics of bronchiolitis and pneumonia worldwide. In most cases the infection with RSV heals without sequelae, yet RSV infection can cause lung function deterioration and in some circumstances, years of recurrent wheezing or asthma may ensue. Overall RSV accounts for an estimated2% of the hospitalization rate among infants less than 1 year of age. This rate increases 4–5-fold among high-risk patients such as premature infants and those with chronic lung disease or complicated congenital heart disease.


Currently there is only one possibility to prevent infections of at-risk patients with RSV, namely immuno-prophylaxis with palivizumab/Synagis, marketed by MedImmune. However, the response to palivizumab is variable among individuals, and sometimes palivizumab fails to prevent RSV infections effectively.


Due to the lack of better antibodies, lack of effective anti-viral treatment and lack of an effective preventive vaccine for RSV, there is a substantial medical need for more efficacious prophylactic immunizations, e.g. by antibody.


Kenta Biotech had developed a fully human monoclonal antibody (KBRV201) derived from B-cells of a human donor. KBRV201 is of the human IgG1 isotype with specificity and very high affinity for the F-protein of human respiratory syncytial virus (hRSV). KBRV201 has been tested for recognition and neutralization of hRSV strains -A, -B and –Long, and KBRV201 could neutralize in vitro all strains tested with higher efficacy than other anti-F-protein mAb.




KBRV201 successfully recognizes 22 clinical isolates from children infected with RSV, including one isolate with a mutated F-protein. Overall KBRV201 has demonstrated superiority in every experiment performed, and KBRV201 is currently undergoing extensive testing in animal models.

14009 NW Harbor Ln, Portland, OR 97229, USA.


Follow us
Copyright © 2025 Kenta Biotech AG
English (UK) English (US)